Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-24 Sale |
2020-12-29 4:01 pm |
Fusion Pharmaceuticals Inc. | FUSN | ADAMS STREET PARTNERS LLC 10% Owner |
3,800 | $12.32 | $46,816 | 1,457,115 (Indirect) |
View |
| 2020-12-23 Sale |
2020-12-28 4:02 pm |
Fusion Pharmaceuticals Inc. | FUSN | ADAMS STREET PARTNERS LLC 10% Owner |
4,569 | $12.39 | $56,610 | 1,458,699 (Indirect) |
View |
| 2020-06-30 Purchase |
2020-07-02 4:58 pm |
Fusion Pharmaceuticals Inc. | FUSN | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner |
725,000 | $17 | $12,325,000 | 3,759,634 (Indirect) |
View |
| 2020-06-30 Purchase |
2020-07-02 4:34 pm |
Fusion Pharmaceuticals Inc. | FUSN | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G Former 10% Owner |
250,000 | $17 | $4,250,000 | 2,551,794 (Indirect) |
View |
| 2020-06-30 Purchase |
2020-07-02 4:05 pm |
Fusion Pharmaceuticals Inc. | FUSN | O'Leary James J Chief Medical Officer |
300 | $17 | $5,100 | 300 (Direct) |
View |
| 2020-06-30 Purchase |
2020-07-02 4:05 pm |
Fusion Pharmaceuticals Inc. | FUSN | Preston Heather Director |
8,823 | $17 | $149,991 | 8,823 (Direct) |
View |
| 2020-06-30 Purchase |
2020-07-02 4:04 pm |
Fusion Pharmaceuticals Inc. | FUSN | Crowley John J Chief Financial Officer |
6,500 | $17 | $110,500 | 6,500 (Direct) |
View |
| 2020-06-30 Purchase |
2020-07-02 4:03 pm |
Fusion Pharmaceuticals Inc. | FUSN | Khuong Chau Quang Director |
898,000 | $17 | $15,266,000 | 192,100 (Indirect) |
View |
| 2020-06-30 Purchase |
2020-07-02 4:02 pm |
Fusion Pharmaceuticals Inc. | FUSN | Christenson Johan Director |
240,000 | $17 | $4,080,000 | 3,807,247 (Indirect) |
View |
| 2020-06-30 Purchase |
2020-07-02 4:02 pm |
Fusion Pharmaceuticals Inc. | FUSN | HealthCap VII L.P. HealthCap VII GP S.A. 10% Owner |
240,000 | $17 | $4,080,000 | 3,807,247 (Indirect) |
View |
| 2020-06-30 Purchase |
2020-07-02 4:02 pm |
Fusion Pharmaceuticals Inc. | FUSN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
898,000 | $17 | $15,266,000 | 192,100 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-04 Option Award |
2021-06-07 4:15 pm |
N/A 2031-06-03 |
Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2021-06-04 Option Award |
2021-06-07 4:14 pm |
N/A 2031-06-03 |
Fusion Pharmaceuticals Inc. | FUSN | Duncan Barbara Gayle Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2021-06-04 Option Award |
2021-06-07 4:13 pm |
N/A 2031-06-03 |
Fusion Pharmaceuticals Inc. | FUSN | CAGNONI PABLO J Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2021-06-04 Option Award |
2021-06-07 4:12 pm |
N/A 2031-06-03 |
Fusion Pharmaceuticals Inc. | FUSN | Bergstrom Donald A Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-01 4:20 pm |
N/A 2031-04-01 |
Fusion Pharmaceuticals Inc. | FUSN | Bergstrom Donald A Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-12 5:42 pm |
N/A 2031-02-10 |
Fusion Pharmaceuticals Inc. | FUSN | Lee Philina Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-08 9:27 pm |
N/A 2031-02-03 |
Fusion Pharmaceuticals Inc. | FUSN | Crowley John J Chief Financial Officer |
138,000 | $0 | 138,000 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-08 9:10 pm |
N/A 2031-02-03 |
Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer |
336,000 | $0 | 336,000 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-08 9:05 pm |
N/A 2031-02-03 |
Fusion Pharmaceuticals Inc. | FUSN | Burak Eric Chief Scientific Officer |
316,600 | $0 | 316,600 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-08 9:01 pm |
N/A 2031-02-03 |
Fusion Pharmaceuticals Inc. | FUSN | O'Leary James J Chief Medical Officer |
114,000 | $0 | 114,000 (Direct) |
View |
| 2020-10-30 Option Award |
2020-11-03 4:56 pm |
N/A 2030-10-29 |
Fusion Pharmaceuticals Inc. | FUSN | Duncan Barbara Gayle Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-06-30 Conversion |
2020-07-02 4:58 pm |
N/A N/A |
Fusion Pharmaceuticals Inc. | FUSN | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner |
19,236,563 | $0 | 3,759,634 (Indirect) |
View |
| 2020-06-30 Conversion |
2020-07-02 4:34 pm |
N/A N/A |
Fusion Pharmaceuticals Inc. | FUSN | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G Former 10% Owner |
14,591,090 | $0 | 2,551,794 (Indirect) |
View |
| 2020-06-30 Conversion |
2020-07-02 4:03 pm |
N/A N/A |
Fusion Pharmaceuticals Inc. | FUSN | Khuong Chau Quang Director |
14,102,821 | $0 | 192,100 (Indirect) |
View |
| 2020-06-30 Conversion |
2020-07-02 4:02 pm |
N/A N/A |
Fusion Pharmaceuticals Inc. | FUSN | Christenson Johan Director |
22,612,796 | $0 | 3,807,247 (Indirect) |
View |
| 2020-06-30 Conversion |
2020-07-02 4:02 pm |
N/A N/A |
Fusion Pharmaceuticals Inc. | FUSN | HealthCap VII L.P. HealthCap VII GP S.A. 10% Owner |
22,612,796 | $0 | 3,807,247 (Indirect) |
View |
| 2020-06-30 Conversion |
2020-07-02 4:02 pm |
N/A N/A |
Fusion Pharmaceuticals Inc. | FUSN | VARIAN MEDICAL SYSTEMS INC 10% Owner |
20,402,918 | $0 | 3,218,632 (Direct) |
View |
| 2020-06-30 Conversion |
2020-07-02 4:02 pm |
N/A N/A |
Fusion Pharmaceuticals Inc. | FUSN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
14,102,821 | $0 | 192,100 (Indirect) |
View |
| 2020-06-30 Conversion |
2020-07-02 4:01 pm |
N/A N/A |
Fusion Pharmaceuticals Inc. | FUSN | ADAMS STREET PARTNERS LLC 10% Owner |
22,201,931 | $0 | 1,460,604 (Indirect) |
View |
| 2020-01-19 Option Award |
2020-06-30 06:49 am |
N/A 2030-01-19 |
Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director |
171,011 | $0 | 171,011 (Direct) |
View |
| 2020-03-16 Option Award |
2020-06-30 06:47 am |
N/A 2030-03-16 |
Fusion Pharmaceuticals Inc. | FUSN | O'Leary James J Chief Medical Officer |
439,744 | $0 | 439,744 (Direct) |
View |
| 2020-02-06 Option Award |
2020-06-30 06:46 am |
N/A 2030-01-10 |
Fusion Pharmaceuticals Inc. | FUSN | Crowley John J Chief Financial Officer |
126,385 | $0 | 126,385 (Direct) |
View |
| 2020-06-25 Option Award |
2020-06-30 06:45 am |
N/A 2030-06-18 |
Fusion Pharmaceuticals Inc. | FUSN | Lamb Damian Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-02-06 Option Award |
2020-06-30 06:41 am |
N/A 2030-01-10 |
Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer |
753,017 | $0 | 753,017 (Direct) |
View |
| 2020-01-10 Option Award |
2020-06-30 06:41 am |
2020-01-10 2022-01-10 |
Fusion Pharmaceuticals Inc. | FUSN | Khuong Chau Quang Director |
389,377 | $0 | 12,267,428 (Indirect) |
View |
| 2020-01-10 Option Award |
2020-06-30 06:37 am |
2020-01-10 2022-01-10 |
Fusion Pharmaceuticals Inc. | FUSN | Christenson Johan Director |
606,233 | $0 | 6,318,449 (Indirect) |
View |
| 2020-06-25 Option Award |
2020-06-30 06:36 am |
N/A 2030-06-18 |
Fusion Pharmaceuticals Inc. | FUSN | CAGNONI PABLO J Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-06-25 Option Award |
2020-06-30 06:34 am |
N/A 2030-06-18 |
Fusion Pharmaceuticals Inc. | FUSN | Preston Heather Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-02-06 Option Award |
2020-06-30 06:33 am |
N/A 2030-01-10 |
Fusion Pharmaceuticals Inc. | FUSN | Burak Eric Chief Scientific Officer |
153,295 | $0 | 153,295 (Direct) |
View |
Ownership |
2020-06-25 8:19 pm |
N/A N/A |
Fusion Pharmaceuticals Inc. | FUSN | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner |
0 | $0 | 2,673,613 (Indirect) |
View |
Ownership |
2020-06-25 8:10 pm |
N/A N/A |
Fusion Pharmaceuticals Inc. | FUSN | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner |
0 | $0 | 3,034,634 (Indirect) |
View |
Ownership |
2020-06-25 8:06 pm |
N/A N/A |
Fusion Pharmaceuticals Inc. | FUSN | ADAMS STREET PARTNERS LLC 10% Owner |
0 | $0 | 3,608,390 (Indirect) |
View |